+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Induced Pluripotent Stem Cells Production Market Size, Share & Trends Analysis Report by Process, by Workflow (Reprogramming, Cell Culture), by Product, by Application, by End Use, by Region, and Segment Forecasts, 2025-2033- Product Image
Induced Pluripotent Stem Cells Production Market Size, Share & Trends Analysis Report by Process, by Workflow (Reprogramming, Cell Culture), by Product, by Application, by End Use, by Region, and Segment Forecasts, 2025-2033- Product Image
New

Induced Pluripotent Stem Cells Production Market Size, Share & Trends Analysis Report by Process, by Workflow (Reprogramming, Cell Culture), by Product, by Application, by End Use, by Region, and Segment Forecasts, 2025-2033

  • PDF Icon

    Report

  • 120 Pages
  • August 2025
  • Region: Global
  • Grand View Research
  • ID: 5899526
Description Jump to:
The global induced pluripotent stem cells production market size was estimated at USD 1.62 billion in 2024 and is projected to reach USD 3.78 billion by 2033, growing at a CAGR of 10.01% from 2025 to 2033. The potential of stem cell-based therapies, the growing incidence of cancer, capital investments for stem cell-based research, and multiple advantages of induced pluripotent stem cells (iPSCs) over embryonic stem cells (ESCs) are driving the market growth significantly.

Expanding Role of iPSC-Derived Cells in Drug Discovery and Toxicology Screening

The use of induced pluripotent stem cell (iPSC)-derived cells in drug discovery and toxicology screening is emerging as a major growth driver for the iPSC production market. Pharma and biotech companies are increasingly adopting iPSC-derived cardiomyocytes, hepatocytes, and neuronal cells to create physiologically relevant in vitro models that better mimic human biology than conventional cell lines or animal models. These models enable high-throughput screening, improve early-stage safety and efficacy assessments, and align with the global push to reduce animal testing, meeting ethical and regulatory expectations.

Global Induced Pluripotent Stem Cells Production Market Report Segmentation

This report forecasts revenue growth and provides an analysis on the latest trends in each of the sub-segments from 2021 to 2033. The analyst has segmented the global induced pluripotent stem cells production market report based on process, workflow, product, application, end use, and region:

Process Outlook (Revenue, USD Million, 2021-2033)

  • Manual iPSC Production Process
  • Automated iPSC Production Process

Workflow Outlook (Revenue, USD Million, 2021-2033)

  • Reprogramming
  • Cell Culture
  • Cell Characterization/Analysis
  • Engineering
  • Others

Product Outlook (Revenue, USD Million, 2021-2033)

  • Instruments/ Devices
  • Automated Platforms
  • Consumables & Kits
  • Media
  • Kits
  • Others
  • Services

Application Outlook (Revenue, USD Million, 2021-2033)

  • Drug Development & Discovery
  • Regenerative Medicine
  • Toxicology Studies
  • Others

End Use Outlook (Revenue, USD Million, 2021-2033)

  • Research & Academic Institutes
  • Biotechnology & Pharmaceutical Companies
  • Hospitals & Clinics

Regional Outlook (Revenue, USD Million, 2021-2033)

  • North America
  • U.S.
  • Canada
  • Mexico
  • Europe
  • UK
  • Germany
  • France
  • Italy
  • Spain
  • Denmark
  • Sweden
  • Norway
  • Asia-Pacific
  • Japan
  • China
  • India
  • Australia
  • Thailand
  • South Korea
  • Latin America
  • Brazil
  • Argentina
  • Middle East and Africa (MEA)
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait

Why should you buy this report?

  • Comprehensive Market Analysis: Gain detailed insights into the industry across major regions and segments.
  • Competitive Landscape: Explore the market presence of key players.
  • Future Trends: Discover the pivotal trends and drivers shaping the future of the market.
  • Actionable Recommendations: Utilize insights to uncover new revenue streams and guide strategic business decisions.

This report addresses:

  • Market intelligence to enable effective decision-making
  • Market estimates and forecasts from 2018 to 2030
  • Growth opportunities and trend analyses
  • Segmental and regional revenue forecasts for market assessment
  • Competition strategy and market share analysis
  • Product innovation listings for you to stay ahead of the curve
  • COVID-19's impact and how to sustain in these fast-evolving markets

This product will be delivered within 2 business days.

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation and Scope
1.2. Market Definitions
1.2.1. Process
1.2.2. Workflow
1.2.3. Product
1.2.4. Application
1.2.5. End Use
1.3. Information analysis
1.4. Market formulation & data visualization
1.5. Data validation & publishing
1.6. Information Procurement
1.6.1. Primary Research
1.7. Information or Data Analysis
1.8. Market Formulation & Validation
1.9. Market Model
1.10. Objectives
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Snapshot
2.3. Competitive Landscape Snapshot
Chapter 3. Market Variables, Trends, & Scope
3.1. Market Lineage Outlook
3.1.1. Parent Market Outlook
3.1.2. Related/Ancillary Market Outlook
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.1.1. Expanding Role of iPSC Derived Cells in Drug Discovery and Toxicology Screening
3.2.1.2. Growing Adoption of iPSC in Personalized and Precision Medicine
3.2.2. Market Restraint Analysis
3.2.2.1. Stringent process control and regulatory challenges
3.2.2.2. High cost of production
3.3. Industry Analysis Tools
3.3.1. Porter's Five Forces Analysis
3.3.2. PESTEL Analysis
Chapter 4. Induced Pluripotent Stem Cells Production Market: Process Business Analysis
4.1. Technology Segment Dashboard
4.2. Global Induced Pluripotent Stem Cells Production Market Process, Movement Analysis
4.3. Global Induced Pluripotent Stem Cells Production Market Size & Trend Analysis, by Process, 2021 to 2033 (USD Million)
4.4. Manual iPSC Production Process
4.4.1. Global Manual iPSC Production Process Market Estimates and Forecasts, 2021-2033 (USD Million)
4.5. Automated iPSC Production Process
4.5.1. Global Automated iPSC Production Process Market Estimates and Forecasts, 2021-2033 (USD Million)
Chapter 5. Induced Pluripotent Stem Cells Production Market: Workflow Business Analysis
5.1. Workflow Segment Dashboard
5.2. Global Induced Pluripotent Stem Cells Production Market Workflow Movement Analysis
5.3. Global Induced Pluripotent Stem Cells Production Market Size & Trend Analysis, by Workflow, 2021 to 2033 (USD Million)
5.4. Reprogramming
5.4.1. Global Reprogramming Market Estimates and Forecasts, 2021-2033 (USD Million)
5.5. Cell Culture
5.5.1. Global Cell Culture Market Estimates and Forecasts, 2021-2033 (USD Million)
5.6. Cell Characterization/Analysis
5.6.1. Global Cell Characterization/Analysis Market Estimates and Forecasts, 2021-2033 (USD Million)
5.7. Engineering
5.7.1. Global Engineering Market Estimates and Forecasts, 2021-2033 (USD Million)
5.8. Others
5.8.1. Global Others Market Estimates and Forecasts, 2021-2033 (USD Million)
Chapter 6. Induced Pluripotent Stem Cells Production Market: Product Business Analysis
6.1. Product Segment Dashboard
6.2. Global Induced Pluripotent Stem Cells Production Market Product Movement Analysis
6.3. Global Induced Pluripotent Stem Cells Production Market Size & Trend Analysis, by Product, 2021 to 2033 (USD Million)
6.4. Instrument/Devices
6.4.1. Global Instrument/Devices Market Estimates and Forecasts, 2021-2033 (USD Million)
6.5. Automated Platforms
6.5.1. Global Automated Platforms Market Estimates and Forecasts, 2021-2033 (USD Million)
6.6. Consumables & Kits
6.6.1. Global Consumables & Kits Market Estimates and Forecasts, 2021-2033 (USD Million)
6.6.2. Media
6.6.2.1. Global Media Market Estimates and Forecasts, 2021-2033 (USD Million)
6.6.3. Kits
6.6.3.1. Global Kits Market Estimates and Forecasts, 2021-2033 (USD Million)
6.6.4. Others
6.6.4.1. Global Others Market Estimates and Forecasts, 2021-2033 (USD Million)
6.7. Services
6.7.1. Global Services Market Estimates and Forecasts, 2021-2033 (USD Million)
Chapter 7. Induced Pluripotent Stem Cells Production Market: Application Business Analysis
7.1. Sample Type Segment Dashboard
7.2. Global Induced Pluripotent Stem Cells Production Market Application Movement Analysis
7.3. Global Induced Pluripotent Stem Cells Production Market Size & Trend Analysis, by Application, 2021 to 2033 (USD Million)
7.4. Drug Development and Discovery
7.4.1. Global Drug Development and Discovery Market Estimates and Forecasts, 2021-2033 (USD Million)
7.5. Regenerative Medicine
7.5.1. Global Regenerative Medicine Market Estimates and Forecasts, 2021-2033 (USD Million)
7.6. Toxicology Studies
7.6.1. Global Toxicology Studies Market Estimates and Forecasts, 2021-2033 (USD Million)
7.7. Others
7.7.1. Global Others Market Estimates and Forecasts, 2021-2033 (USD Million)
Chapter 8. Induced Pluripotent Stem Cells Production Market: End Use Business Analysis
8.1. End Use Segment Dashboard
8.2. Global Induced Pluripotent Stem Cells Production Market End Use Movement Analysis
8.3. Global Induced Pluripotent Stem Cells Production Market Size & Trend Analysis, by End Use, 2021 to 2033 (USD Million)
8.4. Research & Academic Institutes
8.4.1. Global Research & Academic Institutes Market Estimates and Forecasts, 2021-2033 (USD Million)
8.5. Biotechnology & Pharmaceutical Companies
8.5.1. Global Biotechnology & Pharmaceutical Companies Market Estimates and Forecasts, 2021-2033 (USD Million)
8.6. Hospitals & Clinics
8.6.1. Global Hospitals & Clinics Market Estimates and Forecasts, 2021-2033 (USD Million)
Chapter 9. Induced Pluripotent Stem Cells Production Market: Regional Estimates & Trend Analysis by Process, Workflow, Product, Application, & End Use
9.1. Regional Dashboard
9.2. Market Size & Forecasts and Trend Analysis, 2021 to 2033
9.3. North America
9.3.1. North America Induced Pluripotent Stem Cells Production Market Estimates and Forecasts, 2021-2033 (USD Million)
9.3.2. U.S.
9.3.2.1. Key Country Dynamics
9.3.2.2. Competitive Scenario
9.3.2.3. Regulatory Framework
9.3.2.4. U.S. Induced Pluripotent Stem Cells Production Market Estimates and Forecasts, 2021-2033 (USD Million)
9.3.3. Canada
9.3.3.1. Key Country Dynamics
9.3.3.2. Competitive Scenario
9.3.3.3. Regulatory Framework
9.3.3.4. Canada Induced Pluripotent Stem Cells Production Market Estimates and Forecasts, 2021-2033 (USD Million)
9.3.4. Mexico
9.3.4.1. Key Country Dynamics
9.3.4.2. Competitive Scenario
9.3.4.3. Regulatory Framework
9.3.4.4. Mexico Induced Pluripotent Stem Cells Production Market Estimates and Forecasts, 2021-2033 (USD Million)
9.4. Europe
9.4.1. Europe Induced Pluripotent Stem Cells Production Market Estimates and Forecasts, 2021-2033 (USD Million)
9.4.2. UK
9.4.2.1. Key Country Dynamics
9.4.2.2. Competitive Scenario
9.4.2.3. Regulatory Framework
9.4.2.4. UK Induced Pluripotent Stem Cells Production Market Estimates and Forecasts, 2021-2033 (USD Million)
9.4.3. Germany
9.4.3.1. Key Country Dynamics
9.4.3.2. Competitive Scenario
9.4.3.3. Regulatory Framework
9.4.3.4. Germany Induced Pluripotent Stem Cells Production Market Estimates and Forecasts, 2021-2033 (USD Million)
9.4.4. France
9.4.4.1. Key Country Dynamics
9.4.4.2. Competitive Scenario
9.4.4.3. Regulatory Framework
9.4.4.4. France Induced Pluripotent Stem Cells Production Market Estimates and Forecasts, 2021-2033 (USD Million)
9.4.5. Italy
9.4.5.1. Key Country Dynamics
9.4.5.2. Competitive Scenario
9.4.5.3. Regulatory Framework
9.4.5.4. Italy Induced Pluripotent Stem Cells Production Market Estimates and Forecasts, 2021-2033 (USD Million)
9.4.6. Spain
9.4.6.1. Key Country Dynamics
9.4.6.2. Competitive Scenario
9.4.6.3. Regulatory Framework
9.4.6.4. Spain Induced Pluripotent Stem Cells Production Market Estimates and Forecasts, 2021-2033 (USD Million)
9.4.7. Denmark
9.4.7.1. Key Country Dynamics
9.4.7.2. Competitive Scenario
9.4.7.3. Regulatory Framework
9.4.7.4. Denmark Induced Pluripotent Stem Cells Production Market Estimates and Forecasts, 2021-2033 (USD Million)
9.4.8. Sweden
9.4.8.1. Key Country Dynamics
9.4.8.2. Competitive Scenario
9.4.8.3. Regulatory Framework
9.4.8.4. Sweden Induced Pluripotent Stem Cells Production Market Estimates and Forecasts, 2021-2033 (USD Million)
9.4.9. Norway
9.4.9.1. Key Country Dynamics
9.4.9.2. Competitive Scenario
9.4.9.3. Regulatory Framework
9.4.9.4. Norway Induced Pluripotent Stem Cells Production Market Estimates and Forecasts, 2021-2033 (USD Million)
9.5. Asia-Pacific
9.5.1. Asia-Pacific Induced Pluripotent Stem Cells Production Market Estimates and Forecasts, 2021-2033 (USD Million)
9.5.2. Japan
9.5.2.1. Key Country Dynamics
9.5.2.2. Competitive Scenario
9.5.2.3. Regulatory Framework
9.5.2.4. Japan Induced Pluripotent Stem Cells Production Market Estimates and Forecasts, 2021-2033 (USD Million)
9.5.3. China
9.5.3.1. Key Country Dynamics
9.5.3.2. Competitive Scenario
9.5.3.3. Regulatory Framework
9.5.3.4. China Induced Pluripotent Stem Cells Production Market Estimates and Forecasts, 2021-2033 (USD Million)
9.5.4. India
9.5.4.1. Key Country Dynamics
9.5.4.2. Competitive Scenario
9.5.4.3. Regulatory Framework
9.5.4.4. India Induced Pluripotent Stem Cells Production Market Estimates and Forecasts, 2021-2033 (USD Million)
9.5.5. Australia
9.5.5.1. Key Country Dynamics
9.5.5.2. Competitive Scenario
9.5.5.3. Regulatory Framework
9.5.5.4. Australia Induced Pluripotent Stem Cells Production Market Estimates and Forecasts, 2021-2033 (USD Million)
9.5.6. Thailand
9.5.6.1. Key Country Dynamics
9.5.6.2. Competitive Scenario
9.5.6.3. Regulatory Framework
9.5.6.4. Thailand Induced Pluripotent Stem Cells Production Market Estimates and Forecasts, 2021-2033 (USD Million)
9.5.7. South Korea
9.5.7.1. Key Country Dynamics
9.5.7.2. Competitive Scenario
9.5.7.3. Regulatory Framework
9.5.7.4. South Korea Induced Pluripotent Stem Cells Production Market Estimates and Forecasts, 2021-2033 (USD Million)
9.6. Latin America
9.6.1. Latin America Induced Pluripotent Stem Cells Production Market Estimates and Forecasts, 2021-2033 (USD Million)
9.6.2. Brazil
9.6.2.1. Key Country Dynamics
9.6.2.2. Competitive Scenario
9.6.2.3. Regulatory Framework
9.6.2.4. Brazil Induced Pluripotent Stem Cells Production Market Estimates and Forecasts, 2021-2033 (USD Million)
9.6.3. Argentina
9.6.3.1. Key Country Dynamics
9.6.3.2. Competitive Scenario
9.6.3.3. Regulatory Framework
9.6.3.4. Argentina Induced Pluripotent Stem Cells Production Market Estimates and Forecasts, 2021-2033 (USD Million)
9.7. MEA
9.7.1. MEA Induced Pluripotent Stem Cells Production Market Estimates and Forecasts, 2021-2033 (USD Million)
9.7.2. South Africa
9.7.2.1. Key Country Dynamics
9.7.2.2. Competitive Scenario
9.7.2.3. Regulatory Framework
9.7.2.4. South Africa Induced Pluripotent Stem Cells Production Market Estimates and Forecasts, 2021-2033 (USD Million)
9.7.3. Saudi Arabia
9.7.3.1. Key Country Dynamics
9.7.3.2. Competitive Scenario
9.7.3.3. Regulatory Framework
9.7.3.4. Saudi Arabia Induced Pluripotent Stem Cells Production Market Estimates and Forecasts, 2021-2033 (USD Million)
9.7.4. UAE
9.7.4.1. Key Country Dynamics
9.7.4.2. Competitive Scenario
9.7.4.3. Regulatory Framework
9.7.4.4. UAE Induced Pluripotent Stem Cells Production Market Estimates and Forecasts, 2021-2033 (USD Million)
9.7.5. Kuwait
9.7.5.1. Key Country Dynamics
9.7.5.2. Competitive Scenario
9.7.5.3. Regulatory Framework
9.7.5.4. Kuwait Induced Pluripotent Stem Cells Production Market Estimates and Forecasts, 2021-2033 (USD Million)
Chapter 10. Competitive Landscape
10.1. Participant Categorization
10.2. Strategy Mapping
10.3. Company Market Position Analysis, 2024
10.4. Participant’s Overview
10.4.1. Lonza
10.4.1.1. Overview
10.4.1.2. Financial Performance
10.4.1.3. Product Benchmarking
10.4.1.4. Strategic Initiatives
10.4.2. Axol Bioscience Ltd.
10.4.2.1. Overview
10.4.2.2. Financial Performance
10.4.2.3. Product Benchmarking
10.4.2.4. Strategic Initiatives
10.4.3. Evotec
10.4.3.1. Overview
10.4.3.2. Financial Performance
10.4.3.3. Product Benchmarking
10.4.3.4. Strategic Initiatives
10.4.4. Hitachi, Ltd.
10.4.4.1. Overview
10.4.4.2. Financial Performance
10.4.4.3. Product Benchmarking
10.4.4.4. Strategic Initiatives
10.4.5. REPROCELL Inc.
10.4.5.1. Overview
10.4.5.2. Financial Performance
10.4.5.3. Product Benchmarking
10.4.5.4. Strategic Initiatives
10.4.6. Merck KGaA
10.4.6.1. Overview
10.4.6.2. Financial Performance
10.4.6.3. Product Benchmarking
10.4.6.4. Strategic Initiatives
10.4.7. Fate Therapeutics
10.4.7.1. Overview
10.4.7.2. Financial Performance
10.4.7.3. Product Benchmarking
10.4.7.4. Strategic Initiatives
10.4.8. Thermo Fisher Scientific, Inc.
10.4.8.1. Overview
10.4.8.2. Financial Performance
10.4.8.3. Product Benchmarking
10.4.8.4. Strategic Initiatives
10.4.9. StemCellsFactory III
10.4.9.1. Overview
10.4.9.2. Financial Performance
10.4.9.3. Product Benchmarking
10.4.9.4. Strategic Initiatives
10.4.10. Applied StemCells, Inc.
10.4.10.1. Overview
10.4.10.2. Financial Performance
10.4.10.3. Product Benchmarking
10.4.10.4. Strategic Initiatives
List of Tables
Table 1 List of secondary sources
Table 2 List of abbreviations
Table 3 Global induced pluripotent stem cells production market, by product, 2021-2033 (USD Million)
Table 4 Global induced pluripotent stem cells production market, by process, 2021-2033 (USD Million)
Table 5 Global induced pluripotent stem cells production market, by workflow, 2021-2033 (USD Million)
Table 6 Global induced pluripotent stem cells production market, by application, 2021-2033 (USD Million)
Table 7 Global induced pluripotent stem cells production market, by end use, 2021-2033 (USD Million)
Table 8 Global induced pluripotent stem cells production market, by region, 2021-2033 (USD Million)
Table 9 North America induced pluripotent stem cells production market, by country, 2021-2033 (USD Million)
Table 10 North America induced pluripotent stem cells production market, by product, 2021-2033 (USD Million)
Table 11 North America induced pluripotent stem cells production market, by process, 2021-2033 (USD Million)
Table 12 North America induced pluripotent stem cells production market, by workflow, 2021-2033 (USD Million)
Table 13 North America induced pluripotent stem cells production market, by application, 2021-2033 (USD Million)
Table 14 North America induced pluripotent stem cells production market, by end use, 2021-2033 (USD Million)
Table 15 U.S. induced pluripotent stem cells production market, by product, 2021-2033 (USD Million)
Table 16 U.S. induced pluripotent stem cells production market, by process, 2021-2033 (USD Million)
Table 17 U.S. induced pluripotent stem cells production market, by workflow, 2021-2033 (USD Million)
Table 18 U.S. induced pluripotent stem cells production market, by application, 2021-2033 (USD Million)
Table 19 U.S. induced pluripotent stem cells production market, by end use, 2021-2033 (USD Million)
Table 20 Canada induced pluripotent stem cells production market, by product, 2021-2033 (USD Million)
Table 21 Canada induced pluripotent stem cells production market, by process, 2021-2033 (USD Million)
Table 22 Canada induced pluripotent stem cells production market, by workflow, 2021-2033 (USD Million)
Table 23 Canada induced pluripotent stem cells production market, by application, 2021-2033 (USD Million)
Table 24 Canada induced pluripotent stem cells production market, by end use, 2021-2033 (USD Million)
Table 25 Mexico induced pluripotent stem cells production market, by product, 2021-2033 (USD Million)
Table 26 Mexico induced pluripotent stem cells production market, by process, 2021-2033 (USD Million)
Table 27 Mexico induced pluripotent stem cells production market, by workflow, 2021-2033 (USD Million)
Table 28 Mexico induced pluripotent stem cells production market, by application, 2021-2033 (USD Million)
Table 29 Mexico induced pluripotent stem cells production market, by end use, 2021-2033 (USD Million)
Table 30 Europe induced pluripotent stem cells production market, by country, 2021-2033 (USD Million)
Table 31 Europe induced pluripotent stem cells production market, by product, 2021-2033 (USD Million)
Table 32 Europe induced pluripotent stem cells production market, by process, 2021-2033 (USD Million)
Table 33 Europe induced pluripotent stem cells production market, by workflow, 2021-2033 (USD Million)
Table 34 Europe induced pluripotent stem cells production market, by application, 2021-2033 (USD Million)
Table 35 Europe induced pluripotent stem cells production market, by end use, 2021-2033 (USD Million)
Table 36 UK induced pluripotent stem cells production market, by product, 2021-2033 (USD Million)
Table 37 UK induced pluripotent stem cells production market, by process, 2021-2033 (USD Million)
Table 38 UK induced pluripotent stem cells production market, by workflow, 2021-2033 (USD Million)
Table 39 UK induced pluripotent stem cells production market, by application, 2021-2033 (USD Million)
Table 40 UK induced pluripotent stem cells production market, by end use, 2021-2033 (USD Million)
Table 41 Germany induced pluripotent stem cells production market, by product, 2021-2033 (USD Million)
Table 42 Germany induced pluripotent stem cells production market, by process, 2021-2033 (USD Million)
Table 43 Germany induced pluripotent stem cells production market, by workflow, 2021-2033 (USD Million)
Table 44 Germany induced pluripotent stem cells production market, by application, 2021-2033 (USD Million)
Table 45 Germany induced pluripotent stem cells production market, by end use, 2021-2033 (USD Million)
Table 46 France induced pluripotent stem cells production market, by product, 2021-2033 (USD Million)
Table 47 France induced pluripotent stem cells production market, by process, 2021-2033 (USD Million)
Table 48 France induced pluripotent stem cells production market, by workflow, 2021-2033 (USD Million)
Table 49 France induced pluripotent stem cells production market, by application, 2021-2033 (USD Million)
Table 50 France induced pluripotent stem cells production market, by end use, 2021-2033 (USD Million)
Table 51 Italy induced pluripotent stem cells production market, by product, 2021-2033 (USD Million)
Table 52 Italy induced pluripotent stem cells production market, by process, 2021-2033 (USD Million)
Table 53 Italy induced pluripotent stem cells production market, by workflow, 2021-2033 (USD Million)
Table 54 Italy induced pluripotent stem cells production market, by application, 2021-2033 (USD Million)
Table 55 Italy induced pluripotent stem cells production market, by end use, 2021-2033 (USD Million)
Table 56 Spain induced pluripotent stem cells production market, by product, 2021-2033 (USD Million)
Table 57 Spain induced pluripotent stem cells production market, by process, 2021-2033 (USD Million)
Table 58 Spain induced pluripotent stem cells production market, by workflow, 2021-2033 (USD Million)
Table 59 Spain induced pluripotent stem cells production market, by application, 2021-2033 (USD Million)
Table 60 Spain induced pluripotent stem cells production market, by end use, 2021-2033 (USD Million)
Table 61 Denmark induced pluripotent stem cells production market, by product, 2021-2033 (USD Million)
Table 62 Denmark induced pluripotent stem cells production market, by process, 2021-2033 (USD Million)
Table 63 Denmark induced pluripotent stem cells production market, by workflow, 2021-2033 (USD Million)
Table 64 Denmark induced pluripotent stem cells production market, by application, 2021-2033 (USD Million)
Table 65 Denmark induced pluripotent stem cells production market, by end use, 2021-2033 (USD Million)
Table 66 Sweden induced pluripotent stem cells production market, by product, 2021-2033 (USD Million)
Table 67 Sweden induced pluripotent stem cells production market, by process, 2021-2033 (USD Million)
Table 68 Sweden induced pluripotent stem cells production market, by workflow, 2021-2033 (USD Million)
Table 69 Sweden induced pluripotent stem cells production market, by application, 2021-2033 (USD Million)
Table 70 Sweden induced pluripotent stem cells production market, by end use, 2021-2033 (USD Million)
Table 71 Norway induced pluripotent stem cells production market, by product, 2021-2033 (USD Million)
Table 72 Norway induced pluripotent stem cells production market, by process, 2021-2033 (USD Million)
Table 73 Norway induced pluripotent stem cells production market, by workflow, 2021-2033 (USD Million)
Table 74 Norway induced pluripotent stem cells production market, by application, 2021-2033 (USD Million)
Table 75 Norway induced pluripotent stem cells production market, by end use, 2021-2033 (USD Million)
Table 76 Asia-Pacific induced pluripotent stem cells production market, by country, 2021-2033 (USD Million)
Table 77 Asia-Pacific induced pluripotent stem cells production market, by product, 2021-2033 (USD Million)
Table 78 Asia-Pacific induced pluripotent stem cells production market, by process, 2021-2033 (USD Million)
Table 79 Asia-Pacific induced pluripotent stem cells production market, by workflow, 2021-2033 (USD Million)
Table 80 Asia-Pacific induced pluripotent stem cells production market, by application, 2021-2033 (USD Million)
Table 81 Asia-Pacific induced pluripotent stem cells production market, by end use, 2021-2033 (USD Million)
Table 82 Japan induced pluripotent stem cells production market, by product, 2021-2033 (USD Million)
Table 83 Japan induced pluripotent stem cells production market, by process, 2021-2033 (USD Million)
Table 84 Japan induced pluripotent stem cells production market, by workflow, 2021-2033 (USD Million)
Table 85 Japan induced pluripotent stem cells production market, by application, 2021-2033 (USD Million)
Table 86 Japan induced pluripotent stem cells production market, by end use, 2021-2033 (USD Million)
Table 87 China induced pluripotent stem cells production market, by product, 2021-2033 (USD Million)
Table 88 China induced pluripotent stem cells production market, by process, 2021-2033 (USD Million)
Table 89 China induced pluripotent stem cells production market, by workflow, 2021-2033 (USD Million)
Table 90 China induced pluripotent stem cells production market, by application, 2021-2033 (USD Million)
Table 91 China induced pluripotent stem cells production market, by end use, 2021-2033 (USD Million)
Table 92 India induced pluripotent stem cells production market, by product, 2021-2033 (USD Million)
Table 93 India induced pluripotent stem cells production market, by process, 2021-2033 (USD Million)
Table 94 India induced pluripotent stem cells production market, by workflow, 2021-2033 (USD Million)
Table 95 India induced pluripotent stem cells production market, by application, 2021-2033 (USD Million)
Table 96 India induced pluripotent stem cells production market, by end use, 2021-2033 (USD Million)
Table 97 Australia induced pluripotent stem cells production market, by product, 2021-2033 (USD Million)
Table 98 Australia induced pluripotent stem cells production market, by process, 2021-2033 (USD Million)
Table 99 Australia induced pluripotent stem cells production market, by workflow, 2021-2033 (USD Million)
Table 100 Australia induced pluripotent stem cells production market, by application, 2021-2033 (USD Million)
Table 101 Australia induced pluripotent stem cells production market, by end use, 2021-2033 (USD Million)
Table 102 Thailand induced pluripotent stem cells production market, by product, 2021-2033 (USD Million)
Table 103 Thailand induced pluripotent stem cells production market, by process, 2021-2033 (USD Million)
Table 104 Thailand induced pluripotent stem cells production market, by workflow, 2021-2033 (USD Million)
Table 105 Thailand induced pluripotent stem cells production market, by application, 2021-2033 (USD Million)
Table 106 Thailand induced pluripotent stem cells production market, by end use, 2021-2033 (USD Million)
Table 107 South Korea induced pluripotent stem cells production market, by product, 2021-2033 (USD Million)
Table 108 South Korea induced pluripotent stem cells production market, by process, 2021-2033 (USD Million)
Table 109 South Korea induced pluripotent stem cells production market, by workflow, 2021-2033 (USD Million)
Table 110 South Korea induced pluripotent stem cells production market, by application, 2021-2033 (USD Million)
Table 111 South Korea induced pluripotent stem cells production market, by end use, 2021-2033 (USD Million)
Table 112 Latin America induced pluripotent stem cells production market, by country, 2021-2033 (USD Million)
Table 113 Latin America induced pluripotent stem cells production market, by product, 2021-2033 (USD Million)
Table 114 Latin America induced pluripotent stem cells production market, by process, 2021-2033 (USD Million)
Table 115 Latin America induced pluripotent stem cells production market, by workflow, 2021-2033 (USD Million)
Table 116 Latin America induced pluripotent stem cells production market, by application, 2021-2033 (USD Million)
Table 117 Latin America induced pluripotent stem cells production market, by end use, 2021-2033 (USD Million)
Table 118 Brazil induced pluripotent stem cells production market, by product, 2021-2033 (USD Million)
Table 119 Brazil induced pluripotent stem cells production market, by process, 2021-2033 (USD Million)
Table 120 Brazil induced pluripotent stem cells production market, by workflow, 2021-2033 (USD Million)
Table 121 Brazil induced pluripotent stem cells production market, by application, 2021-2033 (USD Million)
Table 122 Brazil induced pluripotent stem cells production market, by end use, 2021-2033 (USD Million)
Table 123 Argentina induced pluripotent stem cells production market, by product, 2021-2033 (USD Million)
Table 124 Argentina induced pluripotent stem cells production market, by process, 2021-2033 (USD Million)
Table 125 Argentina induced pluripotent stem cells production market, by workflow, 2021-2033 (USD Million)
Table 126 Argentina induced pluripotent stem cells production market, by application, 2021-2033 (USD Million)
Table 127 Argentina induced pluripotent stem cells production market, by end use, 2021-2033 (USD Million)
Table 128 Middle East & Africa induced pluripotent stem cells production market, by country, 2021-2033 (USD Million)
Table 129 Middle East & Africa induced pluripotent stem cells production market, by product, 2021-2033 (USD Million)
Table 130 Middle East & Africa induced pluripotent stem cells production market, by process, 2021-2033 (USD Million)
Table 131 Middle East & Africa induced pluripotent stem cells production market, by workflow, 2021-2033 (USD Million)
Table 132 Middle East & Africa induced pluripotent stem cells production market, by application, 2021-2033 (USD Million)
Table 133 Middle East & Africa induced pluripotent stem cells production market, by end use, 2021-2033 (USD Million)
Table 134 South Africa induced pluripotent stem cells production market, by product, 2021-2033 (USD Million)
Table 135 South Africa induced pluripotent stem cells production market, by process, 2021-2033 (USD Million)
Table 136 South Africa induced pluripotent stem cells production market, by workflow, 2021-2033 (USD Million)
Table 137 South Africa induced pluripotent stem cells production market, by application, 2021-2033 (USD Million)
Table 138 South Africa induced pluripotent stem cells production market, by end use, 2021-2033 (USD Million)
Table 139 Saudi Arabia induced pluripotent stem cells production market, by product, 2021-2033 (USD Million)
Table 140 Saudi Arabia induced pluripotent stem cells production market, by process, 2021-2033 (USD Million)
Table 141 Saudi Arabia induced pluripotent stem cells production market, by workflow, 2021-2033 (USD Million)
Table 142 Saudi Arabia induced pluripotent stem cells production market, by application, 2021-2033 (USD Million)
Table 143 Saudi Arabia induced pluripotent stem cells production market, by end use, 2021-2033 (USD Million)
Table 144 UAE induced pluripotent stem cells production market, by product, 2021-2033 (USD Million)
Table 145 UAE induced pluripotent stem cells production market, by process, 2021-2033 (USD Million)
Table 146 UAE induced pluripotent stem cells production market, by workflow, 2021-2033 (USD Million)
Table 147 UAE induced pluripotent stem cells production market, by application, 2021-2033 (USD Million)
Table 148 UAE induced pluripotent stem cells production market, by end use, 2021-2033 (USD Million)
Table 149 Kuwait induced pluripotent stem cells production market, by product, 2021-2033 (USD Million)
Table 150 Kuwait induced pluripotent stem cells production market, by process, 2021-2033 (USD Million)
Table 151 Kuwait induced pluripotent stem cells production market, by workflow, 2021-2033 (USD Million)
Table 152 Kuwait induced pluripotent stem cells production market, by application, 2021-2033 (USD Million)
Table 153 Kuwait induced pluripotent stem cells production market, by end use, 2021-2033 (USD Million)
List of Figures
Figure 1 Induced pluripotent stem cells production market segmentation
Figure 2 Market research process
Figure 3 Data triangulation techniques
Figure 4 Primary research pattern
Figure 5 Market research approaches
Figure 6 Market formulation & validation
Figure 7 Market outlook
Figure 8 Segment snapshot
Figure 9 Competitive landscape snapshot
Figure 10 Parent market outlook
Figure 11 Induced pluripotent stem cells production market driver analysis
Figure 12 Induced pluripotent stem cells production market restraint analysis
Figure 13 Induced pluripotent stem cells production market: Porter's analysis
Figure 14 Induced pluripotent stem cells production market: PESTEL analysis
Figure 15 Induced pluripotent stem cells production market: Product outlook and key takeaways
Figure 16 Induced pluripotent stem cells production market: Product market share analysis, 2021-2033
Figure 17 Global induced pluripotent stem cells production by instruments/devices market, 2021-2033 (USD Million)
Figure 18 Global induced pluripotent stem cells production by automated platforms market, 2021-2033 (USD Million)
Figure 19 Global induced pluripotent stem cells production by consumables & kits market, 2021-2033 (USD Million)
Figure 20 Global induced pluripotent stem cells production by kits market, 2021-2033 (USD Million)
Figure 21 Global induced pluripotent stem cells production by media market, 2021-2033 (USD Million)
Figure 22 Global induced pluripotent stem cells production by others market, 2021-2033 (USD Million)
Figure 23 Global induced pluripotent stem cells production by services market, 2021-2033 (USD Million)
Figure 24 Induced pluripotent stem cells production market: Process outlook and key takeaways
Figure 25 Induced pluripotent stem cells production market: Process market share analysis, 2021-2033
Figure 26 Global induced pluripotent stem cells production by manual iPSC production process market, 2021-2033 (USD Million)
Figure 27 Global induced pluripotent stem cells production by automated iPSC production process market, 2021-2033 (USD Million)
Figure 28 Induced pluripotent stem cells production market: Workflow outlook and key takeaways
Figure 29 Induced pluripotent stem cells production market: Workflow market share analysis, 2021-2033
Figure 30 Global induced pluripotent stem cells production by reprogramming market, 2021-2033 (USD Million)
Figure 31 Global induced pluripotent stem cells production by cell culture market, 2021-2033 (USD Million)
Figure 32 Global induced pluripotent stem cells production by cell characterization/analysis market, 2021-2033 (USD Million)
Figure 33 Global induced pluripotent stem cells production by engineering market, 2021-2033 (USD Million)
Figure 34 Global induced pluripotent stem cells production by others market, 2021-2033 (USD Million)
Figure 35 Induced pluripotent stem cells production market: Application outlook and key takeaways
Figure 36 Induced pluripotent stem cells production market: Application market share analysis, 2021-2033
Figure 37 Global induced pluripotent stem cells production by drug development & discovery market, 2021-2033 (USD Million)
Figure 38 Global induced pluripotent stem cells production by regenerative medicine market, 2021-2033 (USD Million)
Figure 39 Global induced pluripotent stem cells production by toxicology studies market, 2021-2033 (USD Million)
Figure 40 Global induced pluripotent stem cells production by others market, 2021-2033 (USD Million)
Figure 41 Induced pluripotent stem cells production market: End use outlook and key takeaways
Figure 42 Induced pluripotent stem cells production market: End use market share analysis, 2021-2033
Figure 43 Global induced pluripotent stem cells production by research & academic institutes market, 2021-2033 (USD Million)
Figure 44 Global induced pluripotent stem cells production by biotechnology & pharmaceutical companies market, 2021-2033 (USD Million)
Figure 45 Global induced pluripotent stem cells production by hospitals & clinics market, 2021-2033 (USD Million)
Figure 46 Regional marketplace: Key takeaways
Figure 47 North America induced pluripotent stem cells production market estimates and forecast, 2021-2033 (USD Million)
Figure 48 U.S. induced pluripotent stem cells production market estimates and forecast, 2021-2033 (USD Million)
Figure 49 Canada induced pluripotent stem cells production market, 2021-2033 (USD Million)
Figure 50 Mexico induced pluripotent stem cells production market estimates and forecast, 2021-2033 (USD Million)
Figure 51 Europe induced pluripotent stem cells production market estimates and forecast, 2021-2033 (USD Million)
Figure 52 UK induced pluripotent stem cells production market estimates and forecast, 2021-2033 (USD Million)
Figure 53 Germany induced pluripotent stem cells production market estimates and forecast, 2021-2033 (USD Million)
Figure 54 France induced pluripotent stem cells production market estimates and forecast, 2021-2033 (USD Million)
Figure 55 Italy induced pluripotent stem cells production market estimates and forecast, 2021-2033 (USD Million)
Figure 56 Spain induced pluripotent stem cells production market estimates and forecast, 2021-2033 (USD Million)
Figure 57 Denmark induced pluripotent stem cells production market estimates and forecast, 2021-2033 (USD Million)
Figure 58 Sweden induced pluripotent stem cells production market estimates and forecast, 2021-2033 (USD Million)
Figure 59 Norway induced pluripotent stem cells production market estimates and forecast, 2021-2033 (USD Million)
Figure 60 Asia-Pacific induced pluripotent stem cells production market estimates and forecast, 2021-2033 (USD Million)
Figure 61 Japan induced pluripotent stem cells production market estimates and forecast, 2021-2033 (USD Million)
Figure 62 China induced pluripotent stem cells production market estimates and forecast, 2021-2033 (USD Million)
Figure 63 India induced pluripotent stem cells production market estimates and forecast, 2021-2033 (USD Million)
Figure 64 Australia induced pluripotent stem cells production market estimates and forecast, 2021-2033 (USD Million)
Figure 65 Thailand induced pluripotent stem cells production market estimates and forecast, 2021-2033 (USD Million)
Figure 66 South Korea induced pluripotent stem cells production market estimates and forecast, 2021-2033 (USD Million)
Figure 67 Latin America induced pluripotent stem cells production market estimates and forecast, 2021-2033 (USD Million)
Figure 68 Brazil induced pluripotent stem cells production market estimates and forecast, 2021-2033 (USD Million)
Figure 69 Argentina induced pluripotent stem cells production market estimates and forecast, 2021-2033 (USD Million)
Figure 70 MEA induced pluripotent stem cells production market estimates and forecast, 2021-2033 (USD Million)
Figure 71 South Africa induced pluripotent stem cells production market estimates and forecast, 2021-2033 (USD Million)
Figure 72 Saudi Arabia induced pluripotent stem cells production market estimates and forecast, 2021-2033 (USD Million)
Figure 73 UAE induced pluripotent stem cells production market estimates and forecast, 2021-2033 (USD Million)
Figure 74 Kuwait induced pluripotent stem cells production market estimates and forecast, 2021-2033 (USD Million)
Figure 75 Key company categorization
Figure 76 Company market positioning
Figure 77 Market participant categorization
Figure 78 Strategy framework

Companies Mentioned

The major companies profiled in this Induced Pluripotent Stem Cells Production market report include:
  • Lonza
  • Axol Bioscience Ltd.
  • Evotec
  • Hitachi, Ltd.
  • REPROCELL Inc.
  • Merck KGaA
  • Fate Therapeutics
  • Thermo Fisher Scientific, Inc.
  • StemCellsFactory III
  • Applied StemCells, Inc.

Table Information

Report AttributeDetails
No. of Pages120
PublishedAugust 2025
Forecast Period2024 - 2033
Estimated Market Value ( USD ) in 2024 $ 1.62 Billion
Forecasted Market Value ( USD ) by 2033 $ 3.78 Billion
Compound Annual Growth Rate10.0%
Regions CoveredGlobal
No. of Companies Mentioned10

Related Topics

Related Reports

Induced Pluripotent Stem Cell (iPSC) - Global Strategic Business Report - Product Image

Induced Pluripotent Stem Cell (iPSC) - Global Strategic Business Report

  • Report
  • 349 Pages
  • Global
From
Induced Pluripotent Stem Cells Market by Derived Cell Type, by Application, by End-User, and By Region - Product Image

Induced Pluripotent Stem Cells Market by Derived Cell Type, by Application, by End-User, and By Region

  • Report
  • 200 Pages
  • Global
From
Induced Pluripotent Stem Cells Production Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F - Product Image

Induced Pluripotent Stem Cells Production Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F

  • Report
  • 180 Pages
  • Global
From
Induced Pluripotent Stem Cell (IPSC) Market Report 2025 - Product Image

Induced Pluripotent Stem Cell (IPSC) Market Report 2025

  • Report
  • 175 Pages
  • Global
From
Induced Pluripotent Stem Cells Market - Product Image

Induced Pluripotent Stem Cells Market

  • Report
  • 152 Pages
  • Global
From

About the Market

Induced Pluripotent Stem Cells (iPSCs) are a type of stem cell that can be generated from adult cells, such as skin or blood cells. These cells have the potential to differentiate into any type of cell in the body, making them a valuable tool for drug discovery and development. In the pharmaceutical industry, iPSCs are used to create disease models, test drug efficacy, and develop personalized treatments. iPSCs are also used in regenerative medicine, where they can be used to replace damaged or diseased cells. This has the potential to revolutionize the treatment of many diseases, including cancer, diabetes, and neurological disorders. The iPSCs production market is growing rapidly, driven by increasing demand for personalized medicine and regenerative therapies. Companies in this market include Cellular Dynamics International, Takara Bio, and ReproCELL. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.